疫苗接种计划和年龄影响 降低对乙型肝炎疫苗的反应:中亚的一项随机试验
Janyn Heisig1, Zuridin Sh Nurmatov2, Peggy Riese1
1Department Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Pathogens (Basel, Switzerland)
|January 8, 2025
概括
乙型肝炎病毒 (HBV) 疫苗接种坚持改善了缩短的0-1-3方案. 然而,标准的0-1-6计划提供了优越的免疫反应和保护率,表明需要更好的合规策略.
科学领域:
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 乙型肝炎病毒 (HBV) 疫苗接种对于预防感染至关重要,但在中亚,疫苗的覆盖率仍然不够理想.
- 在吉尔吉斯斯坦,对第三剂HBV疫苗的低遵守是严重的公共卫生问题.
- 目前关于该人群对HBV疫苗接种的免疫反应的数据有限.
研究的目的:
- 将缩短的0-1-3HBV疫苗接种计划与吉尔吉斯斯坦的标准0-1-6计划的免疫性和坚持性进行比较.
- 评估不同疫苗接种计划中年龄对疫苗反应的影响.
主要方法:
- 一项涉及17-66岁的随机试验,比较了0-1-6和0-1-3HBV疫苗接种计划.
- 主要结局包括疫苗接种后抗体标位和血清保护率 (≥10 mIU/mL).
- 监测了对疫苗剂量和血液抽取的遵守情况.
主要成果:
- 0-1-3方案在第三剂量和抽血时显示出更好的合规性.
- 标准的0-1-6方案给出了显著更高的疫苗接种后标位 (52比15mIU/mL) 和血清保护率 (85%比64%).
- 年龄较小 (<40岁) 与更好的疫苗保护有关,特别是在0-1-3组.
结论:
- 0-1-6 HBV 疫苗接种计划仍然是最佳免疫反应和血清保护的首选方法.
- 干预措施是必要的,以改善吉尔吉斯斯坦对第三剂疫苗的遵守.
- 需要进一步研究优化HBV疫苗接种策略,以提高符合性和有效性.
更多相关视频
07:25Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
6.8K
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
15.7K
相关概念视频
Vaccinations
44.0K
Overview
44.0K
Cross-reactivity
31.0K
Overview
31.0K
Factors Affecting the Risk of Infection
11.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.3K
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Development of Immunocompetence
283
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
283
